Analysis of the circRNA and T-UCR populations identifies convergent pathways in mouse and human models of Rett syndrome MOL THER-NUCL ACIDS
Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery J CONTROL RELEASE
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study CL LYMPH MYELOM LEUK
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study LANCET HAEMATOL
Natural killer cell receptors and ligand variants modulate response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia HLA